GB8809228D0 - Novel peptides their preparation & use - Google Patents

Novel peptides their preparation & use

Info

Publication number
GB8809228D0
GB8809228D0 GB888809228A GB8809228A GB8809228D0 GB 8809228 D0 GB8809228 D0 GB 8809228D0 GB 888809228 A GB888809228 A GB 888809228A GB 8809228 A GB8809228 A GB 8809228A GB 8809228 D0 GB8809228 D0 GB 8809228D0
Authority
GB
United Kingdom
Prior art keywords
preparation
novel peptides
peptides
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB888809228A
Other versions
GB2203740B (en
GB2203740A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8809228D0 publication Critical patent/GB8809228D0/en
Publication of GB2203740A publication Critical patent/GB2203740A/en
Application granted granted Critical
Publication of GB2203740B publication Critical patent/GB2203740B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB8809228A 1987-04-23 1988-04-19 Novel peptides, their preparation and use Expired - Lifetime GB2203740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3713613 1987-04-23

Publications (3)

Publication Number Publication Date
GB8809228D0 true GB8809228D0 (en) 1988-05-25
GB2203740A GB2203740A (en) 1988-10-26
GB2203740B GB2203740B (en) 1991-04-17

Family

ID=6326146

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8809228A Expired - Lifetime GB2203740B (en) 1987-04-23 1988-04-19 Novel peptides, their preparation and use

Country Status (6)

Country Link
JP (1) JPS63295541A (en)
BE (1) BE1002213A5 (en)
CH (1) CH676003A5 (en)
FR (1) FR2614533A1 (en)
GB (1) GB2203740B (en)
IT (1) IT1219542B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides
DK414389A (en) * 1988-08-24 1990-02-26 Merck & Co Inc PHARMACEUTICAL PREPARATION CONTAINING AN AMINO ACID DERIVATIVE WITH PURINE-INHIBITORIAL EFFECT
EP0374097A3 (en) * 1988-12-15 1991-06-12 Ciba-Geigy Ag Use of peptide isosteres as retroviral protease inhibitors
DE3912829A1 (en) * 1989-04-19 1990-10-25 Bayer Ag USE OF RENININHIBITIC PEPTIDES AS AGENTS AGAINST RETROVIRUS
US5212157A (en) * 1989-06-06 1993-05-18 Bio-Mega, Inc. Enzyme inhibitors
US5126326A (en) * 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives
DE3941235A1 (en) * 1989-12-14 1991-06-20 Bayer Ag NEW PEPTIDES, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE4001236A1 (en) * 1990-01-18 1991-07-25 Bayer Ag New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5559140A (en) * 1991-01-02 1996-09-24 Merrell Pharmaceuticals Inc. Difluoro statone analogs
WO1992012123A1 (en) * 1991-01-02 1992-07-23 Merrell Dow Pharmaceuticals Inc. Anti-viral compounds
DE4126485A1 (en) * 1991-08-10 1993-02-11 Bayer Ag TRIFLUOROMETHYL-CONTAINING PSEUDOPEPTIDE
US5717093A (en) * 1993-07-08 1998-02-10 Merrell Pharmaceuticals Inc. Difluoro statone analogs
JPH09502437A (en) * 1993-09-09 1997-03-11 メレルファーマスーティカルズ インコーポレイテッド Difluorostaton antiviral analogue
US6114380A (en) * 1995-12-18 2000-09-05 Merrell Pharmaceuticals Inc. Difluoro statone analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665055A (en) * 1985-06-17 1987-05-12 Merck & Co., Inc. Peptide renin inhibitors
JPS63503380A (en) * 1986-01-16 1988-12-08 アボット・ラボラトリーズ peptide analogs

Also Published As

Publication number Publication date
IT1219542B (en) 1990-05-18
JPS63295541A (en) 1988-12-01
GB2203740B (en) 1991-04-17
CH676003A5 (en) 1990-11-30
GB2203740A (en) 1988-10-26
BE1002213A5 (en) 1990-10-16
IT8847871A0 (en) 1988-04-20
FR2614533A1 (en) 1988-11-04

Similar Documents

Publication Publication Date Title
GB8801040D0 (en) Novel peptide derivatives their production & use
GB8809228D0 (en) Novel peptides their preparation & use
HU905782D0 (en) Mulluscid preparation containing ferrocomplexes
ZA878336B (en) Peptides
GB8813576D0 (en) Composition & use
JPS6416798A (en) Peptide
JPS646295A (en) Anf-active peptide
GB8619182D0 (en) Peptides & derivatives
GB2193206B (en) Preparation of taurine-containing peptides
ZA878945B (en) Peptides
ZA873796B (en) Peptides
GB8801776D0 (en) Mixture comprising difluorotetrachloroethane & their use
IE871950L (en) "novel peptides"
GB8715867D0 (en) Peptides
GB8715856D0 (en) Peptides
GB8715860D0 (en) Peptides
GB8715862D0 (en) Peptides
GB8715861D0 (en) Peptides
GB8715865D0 (en) Peptides
IE880128L (en) Peptides
IE871539L (en) Peptides
GB8715857D0 (en) Peptides
GB8715864D0 (en) Peptides
GB8715866D0 (en) Peptides
GB8715868D0 (en) Peptides

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee